Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Revelation Biosciences Inc (NQ: REVB )

1.080 +0.020 (+1.89%)
Streaming Delayed Price Updated: 3:59 PM EDT, Jun 9, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Revelation Biosciences Inc

< Previous 1 2 3 4 5 6 7 Next >
Recap: Revelation Biosciences Q1 Earnings
 
Via Benzinga
Revelation Biosciences Inc. Announces Financial Results for the Three Months Ended March 31, 2023 and Recent Corporate Progress
From Revelation Biosciences Inc.
Via Business Wire
Revelation Biosciences And 2 Other Penny Stocks Insiders Are Buying
The Dow Jones closed lower by around 80 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders... 
Via Benzinga
Stocks That Hit 52-Week Lows On Tuesday
  On Tuesday, 65 companies set new 52-week lows. 
Via Benzinga
Why Satsuma Pharmaceuticals Shares Are Trading Higher By 94%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Gainers ContraFect Corporation (NASDAQ: CFRX) shares surged 213% to $2.82. 
Via Benzinga
Revelation Biosciences Inc. Announces Financial Results for the Three and Twelve Months Ended December 31, 2022 and Recent Corporate Progress
From Revelation Biosciences Inc.
Via Business Wire
Revelation Biosciences Inc. Appoints Dr. Julia Bohannon and Dr. Antonio Hernandez to Scientific Advisory Board
From Revelation Biosciences Inc.
Via Business Wire
Revelation Biosciences Inc. to Participate in a Fireside Chat at the 35th Annual Roth Conference
From Revelation Biosciences Inc.
Via Business Wire
Stocks That Hit 52-Week Lows On Tuesday
  During Tuesday, 40 stocks hit new 52-week lows. 
Via Benzinga
Revelation Biosciences Inc. Announces Closing of $15.6 Million Public Offering
From Revelation Biosciences Inc.
Via Business Wire
Why Revelation Biosciences Is Trading 40% Lower Thursday
Revelation Biosciences Inc (NASDAQ: REVB) shares are trading lower by 41.98% Thursday afternoon. The company priced a 3.225 million share offering for gross proceeds of $15.6 million. What Else? 
Via Benzinga
US Stocks Turn Lower; Dow Drops 50 Points
U.S. stocks turned lower midway through trading, with the Dow Jones dropping around 50 points on Thursday. The Dow traded down 0.15% to 33,897.48 while the NASDAQ fell 0.12% to 11,896.28. The S&P 500... 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
 
Via Benzinga
Why Tivic Health Systems Are Trading Lower By 55%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Gainers Hempacco Co., Inc. (NASDAQ: HPCO) rose 296% to $2.99 after declining 6% on Wednesday. 
Via Benzinga
Wall Street Cautiously Optimistic At Midday
The Dow Jones Industrial Average is up 108 points midday. The S&P 500 and Nasdaq Composite are both higher as well. 
Via Talk Markets
Dow Jumps 250 Points; US Jobless Claims Increase Last Week
U.S. stocks traded higher this morning, with the Dow Jones jumping around 250 points on Thursday. The Dow traded up 0.75% to 34,204.99 while the NASDAQ rose 1.15% to 12,047.28. The S&P 500 also rose,... 
Via Benzinga
Revelation Biosciences Inc. Announces Pricing of $15.6 Million Public Offering
From Revelation Biosciences Inc.
Via Business Wire
Why Cardiovascular Systems Shares Are Trading Higher By 48%; Here Are 20 Stocks Moving Premarket
Gainers 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
We're starting off another day of trading with a look at the biggest pre-market stock movers investors need to watch for Wednesday! 
Via InvestorPlace
12 Health Care Stocks Moving In Wednesday's After-Market Session
 
Via Benzinga
Stocks That Hit 52-Week Lows On Wednesday
  On Wednesday, 20 companies achieved new lows for the year. 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
 
Via Benzinga
Revelation Biosciences Reveals Encouraging Preclinical Data From Its Lead Fibrosis Candidate
 
Via Benzinga
Revelation Biosciences Inc. Announces Preclinical Biomarker Data Supporting Activity of REVTx-300
From Revelation Biosciences Inc.
Via Business Wire
Revelation Biosciences Inc. Announces 1-for-35 Reverse Stock Split effective February 1, 2023 and Results of Special Meeting of Stockholders
From Revelation Biosciences Inc.
Via Business Wire
12 Health Care Stocks Moving In Tuesday's After-Market Session
 
Via Benzinga
Why LogicMark Shares Are Trading Lower By Around 25%; Here Are 20 Stocks Moving Premarket
Gainers Axcella Health Inc. (NASDAQ: AXLA) rose 71.7% to $0.7450 in pre-market trading after the company reported regulatory path to registration of AXA1125 for long COVID-19 fatigue. 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
 
Via Benzinga
Revelation Biosciences Inc. Announces Mandatory Unit Separation to Occur on January 13, 2023
From Revelation Biosciences Inc.
Via Business Wire
< Previous 1 2 3 4 5 6 7 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.